| Monkeypox virus infection in humans across 16 countries—April–June 2022 JP Thornhill, S Barkati, S Walmsley, J Rockstroh, A Antinori, LB Harrison, ... New England Journal of Medicine 387 (8), 679-691, 2022 | 1688 | 2022 |
| Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors M Ripa, L Galli, A Poli, C Oltolini, V Spagnuolo, A Mastrangelo, C Muccini, ... Clinical Microbiology and Infection 27 (3), 451-457, 2021 | 368 | 2021 |
| Mpox in people with advanced HIV infection: a global case series O Mitjà, A Alemany, M Marks, JIL Mora, JC Rodríguez-Aldama, MST Silva, ... The Lancet 401 (10380), 939-949, 2023 | 237 | 2023 |
| The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65–74 years and more than 75 years G Guaraldi, A Malagoli, A Calcagno, C Mussi, BM Celesia, F Carli, ... BMC geriatrics 18, 1-10, 2018 | 164 | 2018 |
| Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series JP Thornhill, R Palich, J Ghosn, S Walmsley, D Moschese, CP Cortes, ... The Lancet 400 (10367), 1953-1965, 2022 | 106 | 2022 |
| HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells D Cesana, FR Santoni de Sio, L Rudilosso, P Gallina, A Calabria, ... Nature communications 8 (1), 498, 2017 | 102 | 2017 |
| B-cell subset alterations and correlated factors in HIV-1 infection S Pensieroso, L Galli, S Nozza, N Ruffin, A Castagna, G Tambussi, ... Aids 27 (8), 1209-1217, 2013 | 95 | 2013 |
| Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis S Tasca, G Tambussi, S Nozza, B Capiluppi, MR Zocchi, L Soldini, ... Aids 17 (16), 2291-2298, 2003 | 75 | 2003 |
| Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort A Mondi, A Cozzi‐Lepri, A Tavelli, S Rusconi, F Vichi, ... African Journal of Reproduction and Gynaecological Endoscopy 22 (1), 2019 | 68 | 2019 |
| Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients … S Nozza, L Galli, F Visco, A Soria, F Canducci, S Salpietro, N Gianotti, ... Aids 24 (6), 924-928, 2010 | 64 | 2010 |
| Efficacy of low-dose intermittent subcutaneous interleukin (IL)–2 in antiviral drug–experienced human immunodeficiency virus–infected persons with detectable virus load: a … G Tambussi, S Ghezzi, S Nozza, G Vallanti, L Magenta, M Guffanti, ... The Journal of infectious diseases 183 (10), 1476-1484, 2001 | 61 | 2001 |
| SHARE-net clinical group JP Thornhill, S Barkati, S Walmsley, J Rockstroh, A Antinori, LB Harrison, ... Monkeypox virus infection in humans across 16, 679-91, 2022 | 60 | 2022 |
| Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment HJ Stellbrink, E Le Fevre, A Carr, MS Saag, G Mukwaya, S Nozza, ... Aids 30 (8), 1229-1238, 2016 | 58 | 2016 |
| Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T> C polymorphism M Siccardi, A D'Avolio, S Nozza, M Simiele, L Baietto, FR Stefani, D Moss, ... Pharmacogenetics and genomics 20 (12), 759-765, 2010 | 58 | 2010 |
| Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study Group V Svicher, R D'Arrigo, C Alteri, M Andreoni, G Angarano, A Antinori, ... New Microbiologica 33 (3), 195-206, 2010 | 56 | 2010 |
| The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+T-cell decay and viral load, and with delay of disease … S Bellino, A Tripiciano, O Picconi, V Francavilla, O Longo, C Sgadari, ... Retrovirology 11, 1-8, 2014 | 52 | 2014 |
| Monkeypox infection among men who have sex with men: PCR testing on seminal fluids AR Raccagni, C Candela, D Mileto, D Canetti, E Bruzzesi, A Rizzo, ... The Journal of Infection 85 (5), 573, 2022 | 51 | 2022 |
| Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study S Nozza, A Malagoli, L Maia, A Calcagno, E Focà, G De Socio, S Piconi, ... Journal of Antimicrobial Chemotherapy 72 (10), 2879-2886, 2017 | 49 | 2017 |
| Ageing with HIV: a multidisciplinary review A Calcagno, S Nozza, C Muss, BM Celesia, F Carli, S Piconi, ... Infection 43, 509-522, 2015 | 48 | 2015 |
| Induction of protective antibody response by MF59-adjuvanted 2009 pandemic A/H1N1v influenza vaccine in HIV-1-infected individuals A Kajaste-Rudnitski, L Galli, S Nozza, G Tambussi, A Di Pietro, ... Aids 25 (2), 177-183, 2011 | 48 | 2011 |
